TMCI — TREACE MEDICAL CONCEPTS, INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1630627 ·
Last close
$2.83
Market Cap
$183.59M
52W High
$2.99
52W Low
$1.17
ADV30
549,237
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 47,198,000 | 37,407,000 | -17,167,000 | -17,961,000 | 184,102,000 | 9,544,000 | 106,911,000 |
| Dec 2025 | 62,519,000 | 50,401,000 | -5,922,000 | -9,394,000 | 190,581,000 | 10,708,000 | 103,249,000 |
| Sep 2025 | 50,214,000 | 39,706,000 | -15,676,000 | -16,288,000 | 196,591,000 | 7,686,000 | 107,404,000 |
| Jun 2025 | 47,387,000 | 37,752,000 | -16,974,000 | -17,398,000 | 206,443,000 | 8,052,000 | 108,828,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-15,970,000
Investing CF
$13,251,000
Financing CF
$2,077,000
CapEx
$-13,517,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.94
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-248,992,000
Inventory
$36,031,000
Receivables
$42,155,000
ST Investments
$37,659,000
EBIT TTM
$-53,682,000
Pretax Income TTM
$-59,002,000
Interest Exp TTM
$5,320,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$207,318,000
EBITDA
$-47,678,000
Free Cash Flow
$-5,769,750
Enterprise Value
$200,096,880
Total Cash
$51,854,000
Total Debt
$71,604,000
Shares Out
64,872,976
Trailing EPS
$-0.96
Book Value
$1.19
ROE
-66.9%
ROA
-17.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 212,690,000 | -54,154,000 | -59,002,000 | 190,581,000 | 103,249,000 | — | -15,970,000 |
| Dec 2024 | 209,357,000 | -55,688,000 | -55,743,000 | 217,094,000 | 104,202,000 | — | -37,167,000 |
| Dec 2023 | 187,118,000 | -51,428,000 | -49,527,000 | 251,907,000 | 113,969,000 | — | -34,575,000 |
| Dec 2022 | 141,838,000 | -34,844,000 | -42,815,000 | 159,024,000 | 98,495,000 | — | -30,648,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.90
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INGN | Inogen Inc | $178.15M | $6.58 | — |
| STXS | Stereotaxis, Inc. | $190.59M | $1.95 | — |
| INFU | InfuSystem Holdings, Inc | $191.93M | $9.51 | — |
| KRMD | KORU Medical Systems, Inc. | $192.92M | $4.20 | — |
| APYX | Apyx Medical Corp | $171.26M | $4.09 | — |
News headlines (Yahoo Finance, 1h cache)
Spotlight On Oramed Pharmaceuticals And Two Other Prominent Penny Stocks
2026-05-13 12:05 · Yahoo
Treace Medical Concepts Inc (TMCI) Q1 2026 Earnings Call Highlights: Navigating Revenue ...
2026-05-09 07:02 · Yahoo
Treace Medical Concepts Q1 Earnings Call Highlights
2026-05-09 04:07 · Yahoo
Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates
2026-05-08 12:25 · Yahoo
Treace Medical Concepts Reports First Quarter 2026 Financial Results
2026-05-08 11:05 · Yahoo
How The Treace Medical Concepts (TMCI) Story Is Shifting With Mixed Analyst Expectations
2026-05-03 08:06 · Yahoo
Treace to Report First Quarter 2026 Financial Results on May 8, 2026
2026-04-24 11:05 · Yahoo
How The Treace Medical Concepts (TMCI) Narrative Is Shifting With New Targets And Product Plans
2026-04-17 23:07 · Yahoo
Akebia Therapeutics Leads The Pack Of 3 Promising Penny Stocks
2026-04-13 12:05 · Yahoo
Artivion (AORT) Soars 5.3%: Is Further Upside Left in the Stock?
2026-04-08 07:44 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.